AR014000A1 - Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro - Google Patents

Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro

Info

Publication number
AR014000A1
AR014000A1 ARP980105483A ARP980105483A AR014000A1 AR 014000 A1 AR014000 A1 AR 014000A1 AR P980105483 A ARP980105483 A AR P980105483A AR P980105483 A ARP980105483 A AR P980105483A AR 014000 A1 AR014000 A1 AR 014000A1
Authority
AR
Argentina
Prior art keywords
alkyl
work
arylamine
cyclooxygenase
inhibitors
Prior art date
Application number
ARP980105483A
Other languages
English (en)
Spanish (es)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of AR014000A1 publication Critical patent/AR014000A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/06Anti-spasmodics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP980105483A 1997-10-31 1998-10-30 Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro AR014000A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6388997P 1997-10-31 1997-10-31

Publications (1)

Publication Number Publication Date
AR014000A1 true AR014000A1 (es) 2001-01-31

Family

ID=22052179

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105483A AR014000A1 (es) 1997-10-31 1998-10-30 Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro

Country Status (9)

Country Link
EP (1) EP1027048A2 (https=)
JP (1) JP2001521889A (https=)
AR (1) AR014000A1 (https=)
AU (1) AU758566B2 (https=)
BR (1) BR9813164A (https=)
CA (1) CA2308639A1 (https=)
TW (2) TW200404535A (https=)
WO (1) WO1999022720A2 (https=)
ZA (1) ZA989876B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001274858A1 (en) * 2000-06-08 2001-12-17 Board Of Regents, The University Of Texas System Heterocycle derivatives and methods of use for treating anthrax infection
EP1745791B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6718494A (en) * 1993-05-13 1994-12-12 Merck Frosst Canada Inc. 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US5677318A (en) * 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents

Also Published As

Publication number Publication date
EP1027048A2 (en) 2000-08-16
WO1999022720A3 (en) 1999-08-26
ZA989876B (en) 1999-10-29
JP2001521889A (ja) 2001-11-13
AU1192699A (en) 1999-05-24
TW577739B (en) 2004-03-01
TW200404535A (en) 2004-04-01
BR9813164A (pt) 2000-08-22
WO1999022720A2 (en) 1999-05-14
AU758566B2 (en) 2003-03-27
CA2308639A1 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
CU23116A3 (es) Derivados de bencensulfonamida sustituida, como inhibidores de cox-2
NZ509755A (en) Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
PT772597E (pt) Pirazoles 3,4-substituidos para o tratamento de inflamacao
PH12021500049A1 (en) 2,3-dihydroquinazolin compounds as nav1.8 inhibitors
BRPI0413848A (pt) composto, processo para preparar o composto, composição terapêutica para prevenir inflamação e apoptose, método para prevenir inflamação e apoptose, e, uso de composto inibidor de caspase, ou de seu sal, ou de seu estereoisÈmero
HU9701605D0 (en) New substituted biphenyl or phenylpiridine compounds, a process for their preparation and pharmaceutical composition containing them
UY38186A (es) Sal sódica de n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1-isopropil-1h-pirazol-3-sulfonamida
LV12209A (lv) Ar fenilgrupu aizvietoti heterocikli ka ciklooksigenazes-2 inhibitori
CY1107069T1 (el) Χρηση των αναστολεων της cox-2 σαν ανοσοδιεγερτες στη θεραπεια του hiv ή του aids
ES2120728T3 (es) Inhibidores de la agregacion de plaquetas.
BRPI0417007A (pt) agentes antivirais de diazaindol-dicarbonil-piperazinila
AR014000A1 (es) Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro
DK0659193T3 (da) Blodpladeaggregationsinhibitorer
DK0880504T3 (da) Heterocyclosubstituerede imidazoler til behandling af inflammation
WO2003008412A3 (en) Hetero-bicyclic crf antagonists
AR038199A1 (es) Terapia combinada para el tratamiento de infecciones bacterianas
HUP9901505A2 (hu) Dehidroepiandroszteron és aromatázgátlók kombinációja és e kombináció felhasználása férfiak relatív és abszolút androgénhiányának kezelésére szolgáló gyógyszerkészítmények előállítására
CR20210143A (es) Utilización de un inhibidor de catepsina s contra la formación de anticuerpos anti-fármaco
FR3077201B1 (fr) Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau
AR020306A1 (es) Composicion terapeutica y su uso como inhibidora de la ciclooxigenasa-2 en la prevencion de alteraciones cardiovasculares.
AR035768A1 (es) Compuesto derivado de bencimidazol y su uso en la fabricacion de un medicamento
AR011251A1 (es) Metodo de utilizacion de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de neoplasias
DE50211752D1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion
IT1307330B1 (it) Derivati chinolinici
IT1276171B1 (it) Derivati chinolinici

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure